nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrocodone—Low back pain—Lisinopril—dilated cardiomyopathy	0.102	0.105	CcSEcCtD
Hydrocodone—Hypotensive—Furosemide—dilated cardiomyopathy	0.0538	0.0559	CcSEcCtD
Hydrocodone—Lethargy—Spironolactone—dilated cardiomyopathy	0.0267	0.0277	CcSEcCtD
Hydrocodone—Drug interaction—Furosemide—dilated cardiomyopathy	0.0212	0.022	CcSEcCtD
Hydrocodone—Hearing impaired—Furosemide—dilated cardiomyopathy	0.0206	0.0214	CcSEcCtD
Hydrocodone—Drowsiness—Spironolactone—dilated cardiomyopathy	0.0202	0.021	CcSEcCtD
Hydrocodone—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.0188	0.0196	CcSEcCtD
Hydrocodone—Lightheadedness—Furosemide—dilated cardiomyopathy	0.0176	0.0182	CcSEcCtD
Hydrocodone—Deafness—Furosemide—dilated cardiomyopathy	0.0159	0.0165	CcSEcCtD
Hydrocodone—Drug interaction—Lisinopril—dilated cardiomyopathy	0.0159	0.0165	CcSEcCtD
Hydrocodone—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.0152	0.0157	CcSEcCtD
Hydrocodone—Neck pain—Lisinopril—dilated cardiomyopathy	0.0149	0.0155	CcSEcCtD
Hydrocodone—Musculoskeletal pain—Lisinopril—dilated cardiomyopathy	0.0149	0.0155	CcSEcCtD
Hydrocodone—Lethargy—Furosemide—dilated cardiomyopathy	0.0146	0.0151	CcSEcCtD
Hydrocodone—Urinary retention—Furosemide—dilated cardiomyopathy	0.0136	0.0141	CcSEcCtD
Hydrocodone—Dehydration—Furosemide—dilated cardiomyopathy	0.0133	0.0138	CcSEcCtD
Hydrocodone—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.0132	0.0137	CcSEcCtD
Hydrocodone—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.013	0.0135	CcSEcCtD
Hydrocodone—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.0126	0.0131	CcSEcCtD
Hydrocodone—Somnolence—Spironolactone—dilated cardiomyopathy	0.0115	0.0119	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.0111	0.0115	CcSEcCtD
Hydrocodone—Drowsiness—Furosemide—dilated cardiomyopathy	0.011	0.0114	CcSEcCtD
Hydrocodone—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.0107	0.0111	CcSEcCtD
Hydrocodone—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.0107	0.0111	CcSEcCtD
Hydrocodone—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.0103	0.0106	CcSEcCtD
Hydrocodone—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.0102	0.0106	CcSEcCtD
Hydrocodone—Dehydration—Lisinopril—dilated cardiomyopathy	0.00995	0.0103	CcSEcCtD
Hydrocodone—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00949	0.00985	CcSEcCtD
Hydrocodone—Pruritus—Spironolactone—dilated cardiomyopathy	0.00911	0.00946	CcSEcCtD
Hydrocodone—Angiopathy—Furosemide—dilated cardiomyopathy	0.00895	0.00929	CcSEcCtD
Hydrocodone—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.00859	0.00892	CcSEcCtD
Hydrocodone—Malnutrition—Furosemide—dilated cardiomyopathy	0.00859	0.00891	CcSEcCtD
Hydrocodone—Dizziness—Spironolactone—dilated cardiomyopathy	0.00852	0.00884	CcSEcCtD
Hydrocodone—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00826	0.00857	CcSEcCtD
Hydrocodone—Vomiting—Spironolactone—dilated cardiomyopathy	0.00819	0.0085	CcSEcCtD
Hydrocodone—Rash—Spironolactone—dilated cardiomyopathy	0.00812	0.00843	CcSEcCtD
Hydrocodone—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00811	0.00842	CcSEcCtD
Hydrocodone—Headache—Spironolactone—dilated cardiomyopathy	0.00807	0.00837	CcSEcCtD
Hydrocodone—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.00801	0.00831	CcSEcCtD
Hydrocodone—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00769	0.00798	CcSEcCtD
Hydrocodone—Nausea—Spironolactone—dilated cardiomyopathy	0.00765	0.00794	CcSEcCtD
Hydrocodone—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00729	0.00756	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00726	0.00753	CcSEcCtD
Hydrocodone—Dry mouth—Furosemide—dilated cardiomyopathy	0.00715	0.00742	CcSEcCtD
Hydrocodone—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00687	0.00713	CcSEcCtD
Hydrocodone—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00686	0.00712	CcSEcCtD
Hydrocodone—Skin disorder—Furosemide—dilated cardiomyopathy	0.00681	0.00706	CcSEcCtD
Hydrocodone—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00678	0.00703	CcSEcCtD
Hydrocodone—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00672	0.00697	CcSEcCtD
Hydrocodone—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.00667	0.00692	CcSEcCtD
Hydrocodone—Hypotension—Furosemide—dilated cardiomyopathy	0.00655	0.00679	CcSEcCtD
Hydrocodone—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00648	0.00673	CcSEcCtD
Hydrocodone—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00644	0.00668	CcSEcCtD
Hydrocodone—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00629	0.00653	CcSEcCtD
Hydrocodone—Back pain—Lisinopril—dilated cardiomyopathy	0.00623	0.00647	CcSEcCtD
Hydrocodone—Somnolence—Furosemide—dilated cardiomyopathy	0.00623	0.00646	CcSEcCtD
Hydrocodone—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00619	0.00643	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00605	0.00628	CcSEcCtD
Hydrocodone—Fatigue—Furosemide—dilated cardiomyopathy	0.00604	0.00627	CcSEcCtD
Hydrocodone—Tremor—Lisinopril—dilated cardiomyopathy	0.00604	0.00626	CcSEcCtD
Hydrocodone—Constipation—Furosemide—dilated cardiomyopathy	0.00599	0.00622	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00573	0.00595	CcSEcCtD
Hydrocodone—Cough—Lisinopril—dilated cardiomyopathy	0.00562	0.00583	CcSEcCtD
Hydrocodone—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00554	0.00575	CcSEcCtD
Hydrocodone—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00554	0.00575	CcSEcCtD
Hydrocodone—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00549	0.00569	CcSEcCtD
Hydrocodone—Myalgia—Lisinopril—dilated cardiomyopathy	0.00549	0.00569	CcSEcCtD
Hydrocodone—Anxiety—Lisinopril—dilated cardiomyopathy	0.00547	0.00567	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00545	0.00565	CcSEcCtD
Hydrocodone—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00536	0.00557	CcSEcCtD
Hydrocodone—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00516	0.00536	CcSEcCtD
Hydrocodone—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00515	0.00534	CcSEcCtD
Hydrocodone—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00511	0.0053	CcSEcCtD
Hydrocodone—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00508	0.00527	CcSEcCtD
Hydrocodone—Asthenia—Furosemide—dilated cardiomyopathy	0.00503	0.00522	CcSEcCtD
Hydrocodone—Pruritus—Furosemide—dilated cardiomyopathy	0.00496	0.00514	CcSEcCtD
Hydrocodone—Hypotension—Lisinopril—dilated cardiomyopathy	0.00491	0.0051	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00479	0.00497	CcSEcCtD
Hydrocodone—Insomnia—Lisinopril—dilated cardiomyopathy	0.00476	0.00493	CcSEcCtD
Hydrocodone—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00472	0.0049	CcSEcCtD
Hydrocodone—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00469	0.00486	CcSEcCtD
Hydrocodone—Somnolence—Lisinopril—dilated cardiomyopathy	0.00467	0.00485	CcSEcCtD
Hydrocodone—Dizziness—Furosemide—dilated cardiomyopathy	0.00463	0.00481	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00454	0.00471	CcSEcCtD
Hydrocodone—Fatigue—Lisinopril—dilated cardiomyopathy	0.00453	0.0047	CcSEcCtD
Hydrocodone—Constipation—Lisinopril—dilated cardiomyopathy	0.0045	0.00467	CcSEcCtD
Hydrocodone—Vomiting—Furosemide—dilated cardiomyopathy	0.00446	0.00462	CcSEcCtD
Hydrocodone—Rash—Furosemide—dilated cardiomyopathy	0.00442	0.00458	CcSEcCtD
Hydrocodone—Dermatitis—Furosemide—dilated cardiomyopathy	0.00441	0.00458	CcSEcCtD
Hydrocodone—Headache—Furosemide—dilated cardiomyopathy	0.00439	0.00456	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.0043	0.00446	CcSEcCtD
Hydrocodone—Nausea—Furosemide—dilated cardiomyopathy	0.00416	0.00432	CcSEcCtD
Hydrocodone—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00416	0.00431	CcSEcCtD
Hydrocodone—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00416	0.00431	CcSEcCtD
Hydrocodone—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00387	0.00402	CcSEcCtD
Hydrocodone—Asthenia—Lisinopril—dilated cardiomyopathy	0.00377	0.00391	CcSEcCtD
Hydrocodone—Pruritus—Lisinopril—dilated cardiomyopathy	0.00372	0.00386	CcSEcCtD
Hydrocodone—Dizziness—Lisinopril—dilated cardiomyopathy	0.00348	0.00361	CcSEcCtD
Hydrocodone—Vomiting—Lisinopril—dilated cardiomyopathy	0.00334	0.00347	CcSEcCtD
Hydrocodone—Rash—Lisinopril—dilated cardiomyopathy	0.00332	0.00344	CcSEcCtD
Hydrocodone—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00331	0.00344	CcSEcCtD
Hydrocodone—Headache—Lisinopril—dilated cardiomyopathy	0.00329	0.00342	CcSEcCtD
Hydrocodone—Nausea—Lisinopril—dilated cardiomyopathy	0.00312	0.00324	CcSEcCtD
Hydrocodone—OPRD1—Peptide GPCRs—AGTR2—dilated cardiomyopathy	0.000905	0.0251	CbGpPWpGaD
Hydrocodone—OPRD1—Peptide GPCRs—CXCR3—dilated cardiomyopathy	0.000842	0.0233	CbGpPWpGaD
Hydrocodone—OPRK1—Peptide GPCRs—AGTR2—dilated cardiomyopathy	0.000794	0.022	CbGpPWpGaD
Hydrocodone—OPRD1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000794	0.022	CbGpPWpGaD
Hydrocodone—OPRK1—Peptide GPCRs—CXCR3—dilated cardiomyopathy	0.000738	0.0204	CbGpPWpGaD
Hydrocodone—OPRD1—Peptide GPCRs—AGTR1—dilated cardiomyopathy	0.000696	0.0193	CbGpPWpGaD
Hydrocodone—OPRK1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000696	0.0193	CbGpPWpGaD
Hydrocodone—OPRM1—Peptide GPCRs—AGTR2—dilated cardiomyopathy	0.000671	0.0186	CbGpPWpGaD
Hydrocodone—OPRM1—Peptide GPCRs—CXCR3—dilated cardiomyopathy	0.000624	0.0173	CbGpPWpGaD
Hydrocodone—OPRK1—Peptide GPCRs—AGTR1—dilated cardiomyopathy	0.00061	0.0169	CbGpPWpGaD
Hydrocodone—OPRM1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000588	0.0163	CbGpPWpGaD
Hydrocodone—CYP2D6—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000565	0.0156	CbGpPWpGaD
Hydrocodone—OPRM1—Peptide GPCRs—AGTR1—dilated cardiomyopathy	0.000516	0.0143	CbGpPWpGaD
Hydrocodone—OPRM1—IL4-mediated signaling events—IL10—dilated cardiomyopathy	0.000498	0.0138	CbGpPWpGaD
Hydrocodone—OPRM1—IL4-mediated signaling events—RPS6KB1—dilated cardiomyopathy	0.000485	0.0134	CbGpPWpGaD
Hydrocodone—OPRD1—Peptide ligand-binding receptors—AGTR2—dilated cardiomyopathy	0.000426	0.0118	CbGpPWpGaD
Hydrocodone—OPRD1—Peptide ligand-binding receptors—CXCL2—dilated cardiomyopathy	0.000426	0.0118	CbGpPWpGaD
Hydrocodone—OPRD1—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	0.000396	0.011	CbGpPWpGaD
Hydrocodone—OPRK1—Peptide ligand-binding receptors—CXCL2—dilated cardiomyopathy	0.000373	0.0103	CbGpPWpGaD
Hydrocodone—OPRK1—Peptide ligand-binding receptors—AGTR2—dilated cardiomyopathy	0.000373	0.0103	CbGpPWpGaD
Hydrocodone—OPRD1—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.000359	0.00995	CbGpPWpGaD
Hydrocodone—OPRD1—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.000359	0.00995	CbGpPWpGaD
Hydrocodone—OPRK1—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	0.000347	0.00961	CbGpPWpGaD
Hydrocodone—OPRD1—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.000334	0.00925	CbGpPWpGaD
Hydrocodone—OPRD1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000333	0.00923	CbGpPWpGaD
Hydrocodone—OPRM1—TCR Signaling Pathway—FAS—dilated cardiomyopathy	0.000331	0.00918	CbGpPWpGaD
Hydrocodone—OPRD1—Peptide ligand-binding receptors—AGTR1—dilated cardiomyopathy	0.000327	0.00907	CbGpPWpGaD
Hydrocodone—OPRM1—Peptide ligand-binding receptors—CXCL2—dilated cardiomyopathy	0.000316	0.00874	CbGpPWpGaD
Hydrocodone—OPRM1—Peptide ligand-binding receptors—AGTR2—dilated cardiomyopathy	0.000316	0.00874	CbGpPWpGaD
Hydrocodone—OPRK1—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.000315	0.00872	CbGpPWpGaD
Hydrocodone—OPRK1—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.000315	0.00872	CbGpPWpGaD
Hydrocodone—OPRD1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00031	0.00858	CbGpPWpGaD
Hydrocodone—OPRD1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.0003	0.00831	CbGpPWpGaD
Hydrocodone—OPRM1—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	0.000293	0.00812	CbGpPWpGaD
Hydrocodone—OPRK1—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.000293	0.00811	CbGpPWpGaD
Hydrocodone—OPRK1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000292	0.00809	CbGpPWpGaD
Hydrocodone—OPRK1—Peptide ligand-binding receptors—AGTR1—dilated cardiomyopathy	0.000287	0.00795	CbGpPWpGaD
Hydrocodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000286	0.00791	CbGpPWpGaD
Hydrocodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000286	0.00791	CbGpPWpGaD
Hydrocodone—OPRK1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000272	0.00752	CbGpPWpGaD
Hydrocodone—OPRM1—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.000266	0.00737	CbGpPWpGaD
Hydrocodone—OPRM1—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.000266	0.00737	CbGpPWpGaD
Hydrocodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000266	0.00735	CbGpPWpGaD
Hydrocodone—OPRK1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000263	0.00729	CbGpPWpGaD
Hydrocodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000257	0.00712	CbGpPWpGaD
Hydrocodone—OPRD1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000256	0.0071	CbGpPWpGaD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00025	0.00693	CbGpPWpGaD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00025	0.00693	CbGpPWpGaD
Hydrocodone—OPRM1—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.000247	0.00685	CbGpPWpGaD
Hydrocodone—OPRM1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000247	0.00684	CbGpPWpGaD
Hydrocodone—OPRD1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000243	0.00673	CbGpPWpGaD
Hydrocodone—OPRM1—Peptide ligand-binding receptors—AGTR1—dilated cardiomyopathy	0.000243	0.00672	CbGpPWpGaD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000233	0.00645	CbGpPWpGaD
Hydrocodone—OPRD1—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.00023	0.00638	CbGpPWpGaD
Hydrocodone—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00023	0.00636	CbGpPWpGaD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000225	0.00624	CbGpPWpGaD
Hydrocodone—OPRK1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000225	0.00622	CbGpPWpGaD
Hydrocodone—OPRM1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000222	0.00616	CbGpPWpGaD
Hydrocodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00022	0.00608	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000217	0.00602	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000217	0.00602	CbGpPWpGaD
Hydrocodone—OPRM1—TCR Signaling Pathway—RAF1—dilated cardiomyopathy	0.000215	0.00597	CbGpPWpGaD
Hydrocodone—OPRK1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000213	0.0059	CbGpPWpGaD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000212	0.00586	CbGpPWpGaD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000212	0.00586	CbGpPWpGaD
Hydrocodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000208	0.00577	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000202	0.0056	CbGpPWpGaD
Hydrocodone—OPRK1—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.000202	0.00559	CbGpPWpGaD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000197	0.00545	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000196	0.00542	CbGpPWpGaD
Hydrocodone—OPRD1—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000194	0.00538	CbGpPWpGaD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000193	0.00533	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000191	0.00528	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000191	0.00528	CbGpPWpGaD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000191	0.00528	CbGpPWpGaD
Hydrocodone—OPRM1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00019	0.00526	CbGpPWpGaD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000183	0.00506	CbGpPWpGaD
Hydrocodone—OPRM1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00018	0.00499	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000177	0.00491	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000172	0.00475	CbGpPWpGaD
Hydrocodone—OPRM1—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.000171	0.00473	CbGpPWpGaD
Hydrocodone—OPRK1—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00017	0.00472	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000167	0.00463	CbGpPWpGaD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000163	0.00451	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000161	0.00446	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000161	0.00446	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000159	0.00439	CbGpPWpGaD
Hydrocodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000155	0.00428	CbGpPWpGaD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000154	0.00428	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00015	0.00415	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000147	0.00406	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000145	0.00402	CbGpPWpGaD
Hydrocodone—OPRM1—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000144	0.00399	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000139	0.00385	CbGpPWpGaD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000136	0.00375	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000124	0.00343	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000123	0.0034	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000123	0.0034	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000118	0.00326	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000118	0.00326	CbGpPWpGaD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000115	0.00317	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000114	0.00316	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000112	0.00309	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000112	0.00309	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000111	0.00306	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000108	0.00298	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000108	0.00298	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000104	0.00287	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000103	0.00286	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.0001	0.00278	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.0001	0.00277	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	9.79e-05	0.00271	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	9.79e-05	0.00271	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	9.7e-05	0.00269	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	9.45e-05	0.00262	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	9.11e-05	0.00252	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	9.11e-05	0.00252	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	9.1e-05	0.00252	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	8.97e-05	0.00248	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	8.81e-05	0.00244	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—AGT—dilated cardiomyopathy	8.72e-05	0.00242	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	8.58e-05	0.00238	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	8.47e-05	0.00234	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	8.29e-05	0.00229	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	8.27e-05	0.00229	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	8.27e-05	0.00229	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	8.2e-05	0.00227	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	8.14e-05	0.00225	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	7.86e-05	0.00218	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	7.69e-05	0.00213	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	7.53e-05	0.00208	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	7.45e-05	0.00206	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PSEN2—dilated cardiomyopathy	7.43e-05	0.00206	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	7.14e-05	0.00198	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	7e-05	0.00194	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	6.96e-05	0.00193	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	6.9e-05	0.00191	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—AGT—dilated cardiomyopathy	6.65e-05	0.00184	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	6.64e-05	0.00184	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—AGTR2—dilated cardiomyopathy	6.59e-05	0.00183	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CXCL2—dilated cardiomyopathy	6.59e-05	0.00183	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PSEN2—dilated cardiomyopathy	6.51e-05	0.0018	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	6.49e-05	0.0018	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	6.36e-05	0.00176	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—RAC1—dilated cardiomyopathy	6.32e-05	0.00175	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.13e-05	0.0017	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	6.1e-05	0.00169	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—AGT—dilated cardiomyopathy	6.04e-05	0.00167	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	6.03e-05	0.00167	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—ADRB1—dilated cardiomyopathy	5.94e-05	0.00164	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	5.87e-05	0.00162	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—AGT—dilated cardiomyopathy	5.83e-05	0.00161	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—AGTR2—dilated cardiomyopathy	5.78e-05	0.0016	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CXCL2—dilated cardiomyopathy	5.78e-05	0.0016	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—RAC1—dilated cardiomyopathy	5.54e-05	0.00153	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PSEN2—dilated cardiomyopathy	5.5e-05	0.00152	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CXCR3—dilated cardiomyopathy	5.37e-05	0.00149	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—AGT—dilated cardiomyopathy	5.3e-05	0.00147	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—ADRB1—dilated cardiomyopathy	5.21e-05	0.00144	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	5.16e-05	0.00143	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.07e-05	0.0014	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—AGT—dilated cardiomyopathy	4.93e-05	0.00136	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—AGTR2—dilated cardiomyopathy	4.89e-05	0.00135	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CXCL2—dilated cardiomyopathy	4.89e-05	0.00135	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.81e-05	0.00133	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—RAC1—dilated cardiomyopathy	4.68e-05	0.0013	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CXCR3—dilated cardiomyopathy	4.54e-05	0.00126	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	4.51e-05	0.00125	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—AGT—dilated cardiomyopathy	4.48e-05	0.00124	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—AGTR1—dilated cardiomyopathy	4.45e-05	0.00123	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—ADRB1—dilated cardiomyopathy	4.4e-05	0.00122	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	4.24e-05	0.00117	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.22e-05	0.00117	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.19e-05	0.00116	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.13e-05	0.00114	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	3.84e-05	0.00106	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.76e-05	0.00104	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—RAC1—dilated cardiomyopathy	3.73e-05	0.00103	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.68e-05	0.00102	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.62e-05	0.001	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—AGT—dilated cardiomyopathy	3.57e-05	0.000988	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.56e-05	0.000987	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—RAC1—dilated cardiomyopathy	3.27e-05	0.000907	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—AGT—dilated cardiomyopathy	3.13e-05	0.000866	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.11e-05	0.00086	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.06e-05	0.000848	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.87e-05	0.000796	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—RAC1—dilated cardiomyopathy	2.77e-05	0.000766	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—AGT—dilated cardiomyopathy	2.64e-05	0.000732	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.52e-05	0.000698	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—RAF1—dilated cardiomyopathy	2.48e-05	0.000686	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—RAF1—dilated cardiomyopathy	2.17e-05	0.000601	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.13e-05	0.00059	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—RAF1—dilated cardiomyopathy	1.83e-05	0.000508	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—EGFR—dilated cardiomyopathy	1.7e-05	0.00047	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	1.59e-05	0.000441	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	1.55e-05	0.00043	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—EGFR—dilated cardiomyopathy	1.49e-05	0.000412	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	1.4e-05	0.000387	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—EGFR—dilated cardiomyopathy	1.26e-05	0.000348	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	1.04e-05	0.000289	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	1.02e-05	0.000281	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	9.14e-06	0.000253	CbGpPWpGaD
